News

Collaboration Between Infosys and zooplus Enhances E-Commerce

Collaboration Between Infosys and zooplus Enhances E-Commerce

Strategic Partnership to Revolutionize E-Commerce

Infosys, a prominent name in next-generation digital services and consulting, has entered into a strategic alliance with zooplus, a leading European e-commerce platform, aimed at advancing their digital capabilities. This collaboration marks a significant step as both companies work together to enhance their service capability and scalability.

Establishing a Global Capability Center

The partnership will see the establishment of a cutting-edge Global Capability Center (GCC) in Hyderabad, aiming to cultivate AI-led innovations. The GCC will serve as a hub for driving technological advancements tailored specifically for zooplus, allowing the company to leverage Infosys Topaz, an AI-first offering that utilizes generative AI technologies.

Transforming Operational Efficiency

Through this collaboration, zooplus intends to transform its e-commerce capabilities while enhancing operational efficiency. By focusing on marketing, e-commerce, and supply chain improvements, both companies anticipate significant progress in product management and engineering practices.

Driving Innovation Through AI

Infosys was chosen due to its unique AI-first approach and commitment to productivity and cost-effectiveness. The collaboration seeks to elevate zooplus' customer experience by enhancing their technology and value chain capabilities, demonstrating the importance of AI in future business strategies.

Leadership Perspectives on the Collaboration

Geoffroy Lefebvre, the Chief Executive Officer of zooplus, shared insights on the growth strategy, stating, "At zooplus, we always focus on leveraging data-driven insights to meet customer demands. Our collaboration with Infosys to establish a technology hub reflects our commitment to combining features of their AI-first strategy with robust solutions from Infosys Topaz which will empower us to enhance operational efficiencies and improve customer experience."

Karmesh Vaswani, Executive Vice President & Global Head of Consumer, Retail & Logistics at Infosys, emphasized the importance of this partnership, noting that it's a testament to Infosys' dedication to driving large-scale digital transformation for clients. He stated, "Our collaboration with zooplus underlines our commitment to foster innovation while ensuring sustained growth in the digital marketplace."

About zooplus and Its Vision

zooplus SE stands as Europe’s premier online pet platform, dedicated to catering to pet owners with an extensive array of products, exclusive brand offerings, and valuable insights about pet care. The company’s mission is to create the ultimate pet destination, enabling pet parents to access high-quality products and guidance through a convenient online shopping experience.

Nationwide Service in Europe

Operating across 30 European countries, zooplus is steadily reinforcing its presence in the market by providing reliable delivery and superior customer service. It continuously innovates its offerings to meet the evolving needs of pet parents, making each shopping experience seamless and enjoyable.

About Infosys and Its Impact in the Digital Space

Infosys is at the forefront of digital transformation, leading the way for enterprises worldwide. With a workforce of over 300,000, Infosys empowers organizations in more than 56 countries to refine their digital strategies, leveraging over forty years of experience.

The company emphasizes an AI-first core, facilitating agile digital transformations at scale while continually improving through the exchange of digital skills and ideas. Infosys is firmly committed to sustainability and promoting a diverse and inclusive workplace where talent thrives.

Frequently Asked Questions

What is the main goal of the Infosys and zooplus collaboration?

The primary goal is to enhance zooplus' e-commerce capabilities and operational efficiency through AI-led innovations provided by Infosys.

Where will the new Global Capability Center be located?

The Global Capability Center will be established in Hyderabad, providing a base for technological advancements.

What technology will zooplus utilize from Infosys?

zooplus will utilize Infosys Topaz, an AI-first offering that employs generative AI technologies to drive innovation.

How does this collaboration impact zooplus' customer experience?

This partnership aims to significantly enhance the customer experience by improving technology and refining the value chain capabilities at zooplus.

What is Infosys known for in the digital services space?

Infosys is recognized as a global leader in digital services and consulting, helping enterprises navigate their digital transformations effectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading